Paid Clinical Trials High Point
Discover 1,030 paid clinical trials in High Point, North Carolina. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Pain Neuroscience Education & tDCSThe Effect of Combining Pain Neuroscience Education and Transcranial Direct Current Stimulation on Pain Catastrophizing, Kinesiophobia, and Pain in Patients With Chronic Low Back Pain
Sponsor:
High Point University
Location:
Code:
NCT05571215
Conditions
Chronic Low-back Pain
Catastrophizing Pain
Kinesiophobia
Eligibility Criteria
Sex: All
Age: 18 - 65
Healthy Volunteers: Not accepted
Interventions
Transcranial Direct Current Stimulation
Pain Neuroscience Education
SolrikitugA Study to Evaluate Solrikitug in Participants With COPD (ZION)
Sponsor:
Uniquity One (UNI)
Location:
Code:
NCT06496620
Conditions
COPD
Eligibility Criteria
Sex: All
Age: 40 - 70+
Healthy Volunteers: Not accepted
Interventions
Biological: Solrikitug low dose
Biological: Solrikitug high dose
Placebo
DapsoneDapsone Coronavirus SARS-CoV-2 Trial (DAP-CORONA) COVID-19
Sponsor:
McGill University Health Centre/Research Institute of the McGill University Health Centre
Location:
Code:
NCT04935476
Conditions
COVID-19
Eligibility Criteria
Sex: All
Age: 40+
Healthy Volunteers: Not accepted
Interventions
Dapsone 85 mg PO BID
Placebo 85 mg PO BID
Point-of-Care Troponin IAssessing Chest Pain Using Point-of-Care High-Sensitivity Troponin I in the Emergency Department
Sponsor:
Wake Forest University Health Sciences
Location:
Code:
NCT06899776
Conditions
ACS (Acute Coronary Syndrome)
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Abbott i-STAT point of care (POC) device
CIN-102A Study to Evaluate the Efficacy and Safety of CIN-102 (Deudomperidone) in Adults With Diabetic Gastroparesis
Sponsor:
CinDome Pharma, Inc.
Location:
Code:
NCT05832151
Conditions
Diabetic Gastroparesis
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
CIN-102 Dose 15mg or 10mg
Placebo
Interested in new trials?
Get alerts for new trials in your area by subscribing now
TezepelumabA Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD
Sponsor:
AstraZeneca
Location:
Code:
NCT06883305
Conditions
Chronic Obstructive Pulmonary Disease (COPD)
Eligibility Criteria
Sex: All
Age: 40 - 70+
Healthy Volunteers: Not accepted
Interventions
Tezepelumab
Placebo
ElismetrepA Phase IIb, Randomized, Double-Blind, Placebo-Controlled Study of Elismetrep (K-304) in the Treatment of Migraine
Sponsor:
Kallyope Inc.
Location:
Code:
NCT06848075
Conditions
Acute Migraine
Eligibility Criteria
Sex: All
Age: 18 - 70
Healthy Volunteers: Not accepted
Interventions
Elismetrep (K-304) Dose Level 1
Elismetrep (K-304) Dose level 2
Elismetrep (K-304) Dose level 3
Elismetrep (K-304) Dose level 4
Placebo
RO7790121A Study to Assess the Efficacy and Safety of RO7790121 for Induction and Maintenance Therapy in Participants With Moderately to Severely Active Ulcerative Colitis
Sponsor:
Hoffmann-La Roche
Location:
Code:
NCT06589986
Conditions
Moderately to Severely Active Ulcerative Colitis
Eligibility Criteria
Sex: All
Age: 16 - 70+
Healthy Volunteers: Not accepted
Interventions
RO7790121
Placebo
ZiltivekimabARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With a Heart Attack
Sponsor:
Novo Nordisk A/S
Location:
Code:
NCT06118281
Conditions
Cardiovascular Risk
Acute Myocardial Infarction (AMI)
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Ziltivekimab
Placebo
DDP733A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females
Sponsor:
Dynogen Pharmaceuticals
Location:
Code:
NCT00547469
Conditions
Irritable Bowel Syndrome
Eligibility Criteria
Sex: Female
Age: 18 - 65
Healthy Volunteers: Not accepted
Interventions
DDP733